Article
Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Mar 2016
Poljak Mario, Oštrbenk Anja, Seme Katja, Šterbenc Anja, Jančar Nina, Vrtačnik Bokal Eda
Abstract excerpt
BACKGROUND: Testing cervical smears for the presence of high-risk human papillomaviruses (hrHPV) increases the sensitivity for detecting women with underlying high-grade cervical intraepithelial neoplasia (CIN) and provides better and longer protection against invasive cervical cancer compared to cytology testing alone. The Abbott RealTime High Risk HPV test (RealTime) is a hrHPV DNA test with concurrent partial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
